USP: Excipient Stimuli published for Comments

Recommendation
21 October 2025
Barcelona, Spain
An ECA Course prior to the 28th APIC/CEFIC Global GMP & Regulatory API Conference
In the beginning of September, the stimuli document "Proposed Definitions of Excipient Components- Revisions to 2018 Definitions- PF 49(5)" was published on the USP Pharmacopeial Forum website for comments. Comments on this draft can be submitted until 30 November 2023.
This draft is divided into the following chapters:
- Background
- Newly Proposed Definitions
- Appendix
o Original 2018 Definitions
o History of Concomitant Component - References
Table 1 of the paragraph "Newly Proposed Definitions" shows the new proposals for the excipient components and compares them with the previous definitions of the last valid version from 2018. This is followed by examples for each of the definitions. These include five examples each for main components and minor components as well as seven examples for excipient impurities.
The Stimuli document "Proposed Definitions of Excipient Components- Revisions to 2018 Definitions- PF 49(5)" can be viewed and commented on after a one-time registration on the Pharmacopeial Forum website.
Related GMP News
15.10.2025Data Integrity and the ICH Q7 Guidance - Part II
08.10.2025US FDA Warning Letter: Inadequate Investigation of Complaints
08.10.2025Data Integrity and the ICH Q7 Guidance - Part I
03.09.2025USP: Chapters 'Balances <41>' and 'Weighing on an Analytical Balance <1251>' final
27.08.2025ECHA: 'PFAS' Restrictions updated
20.08.2025EMA/HMA: Nitrosamine Report published